A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.

Clinical trial NCT03549000 · TERMINATED

Trial details

NCT number: NCT03549000
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer (NSCLC)Triple Negative Breast Cancer (TNBC)Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer Microsatellite Stable (MSS)Ovarian Cancer Renal Cell Carcinoma (RCC)Metastatic Castration Resistant Prostate Cancer (mCRPC)

Start date: 2018-07-18
Primary completion: 2022-10-17
Enrollment: 127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.